ASTM Launches a New Cannabis Subcommittee
The leading US testing standards organization ASTM International has launched a new subcommittee to support the growing discussions on cannabis regulations between policymakers, scientists, and the general public.
Medical Cannabis Oils Can Treat Chronic Pain, UK Registry Study Finds
Published in the Journal of Clinical Pharmacology, the study surveyed the first group of UK chronic pain patients prescribed medical cannabis oil.
THC Can Contribute to Birth Defects in Mice, Study Finds
Exposure to THC in the womb could increase the risk that genetically predisposed children are born with facial defects, according to a new rodent study published in the journal Development.
Cannabis Consumers at Higher Risk of Developing Poor Mental Health, Study Suggests
People with a history of cannabis use in their medical records appear to be at a higher risk for developing problems with anxiety, depression, and even more severe mental illnesses such as schizophrenia, according to a new study from researchers at the University of Birmingham.
Can Psilocybin Help Smokers Quit? This Clinical Trial Aims to Find Out
Mydecine Innovations Group has announced its partnership with the renowned psychedelic science researcher Dr Matthew Johnson of Johns Hopkins University to carry the clinical trial.
Seattle Decriminalizes Psilocybin and Other Psychedelics
The US city of Seattle has become the largest city in the country to decriminalize the use of some psychedelic substances, including psilocybin and mescaline.
Could Ketamine Help Tackle Gambling Addiction?
Recruitment is now underway for a first-of-its-kind study investigating the potential of ketamine to fight gambling addiction.
Expanding the Panel of Elemental Contaminants in Cannabis and Hemp Consumer Products by ICP-MS: Do You Know the Cost Difference?
Robert Thomas, a leading heavy metals expert in the cannabis testing sector and principle of the consulting company Scientific Solutions, breaks down the cost differences between testing for four heavy metals and for fifteen.
Ketamine Alone May Effectively Treat Depression, Study Suggests
Ketamine alone may be just as effective as ketamine combined with traditional antidepressants for tackling treatment-resistant depression, a new study has found.
